National Research Corporation Declares Quarterly Dividend
National Research (NASDAQ: NRC) has announced a quarterly cash dividend of $0.12 per share, payable on April 11, 2025, to shareholders of record as of March 28, 2025. The company, doing business as NRC Health, has been a leader in healthcare experience management for over 40 years, focusing on humanizing healthcare through their Human Understanding® approach.
NRC Health specializes in helping healthcare systems develop ongoing relationships with patients through market research and consumer preference analysis. The company's commitment to patient-focused services has earned them the #1 ranking for Healthcare Experience Management in the 2025 Best in KLAS report.
National Research (NASDAQ: NRC) ha annunciato un dividendo in contante trimestrale di 0,12 $ per azione, pagabile l'11 aprile 2025, agli azionisti registrati al 28 marzo 2025. L'azienda, che opera come NRC Health, è un leader nella gestione dell'esperienza sanitaria da oltre 40 anni, concentrandosi sull'umanizzazione della sanità attraverso il loro approccio Human Understanding®.
NRC Health è specializzata nell'aiutare i sistemi sanitari a sviluppare relazioni durature con i pazienti attraverso ricerche di mercato e analisi delle preferenze dei consumatori. L'impegno dell'azienda per servizi incentrati sul paziente le ha valso il primo posto nella gestione dell'esperienza sanitaria nel rapporto 2025 Best in KLAS.
National Research (NASDAQ: NRC) ha anunciado un dividendo en efectivo trimestral de $0.12 por acción, que se pagará el 11 de abril de 2025, a los accionistas registrados al 28 de marzo de 2025. La empresa, que opera como NRC Health, ha sido un líder en la gestión de la experiencia en salud durante más de 40 años, centrándose en humanizar la atención médica a través de su enfoque Human Understanding®.
NRC Health se especializa en ayudar a los sistemas de salud a desarrollar relaciones continuas con los pacientes a través de investigaciones de mercado y análisis de preferencias del consumidor. El compromiso de la empresa con servicios centrados en el paciente le ha valido el primer lugar en la gestión de la experiencia en salud en el informe 2025 Best in KLAS.
National Research (NASDAQ: NRC)는 주당 0.12달러의 분기 현금 배당금을 발표했으며, 2025년 4월 11일에 지급될 예정입니다. 배당금 지급 기준일은 2025년 3월 28일입니다. NRC Health로 운영되는 이 회사는 40년 이상 의료 경험 관리 분야의 선두주자로, Human Understanding® 접근 방식을 통해 의료를 인간화하는 데 주력해 왔습니다.
NRC Health는 시장 조사와 소비자 선호 분석을 통해 의료 시스템이 환자와 지속적인 관계를 발전시키도록 돕는 전문 기업입니다. 환자 중심 서비스에 대한 회사의 헌신은 2025년 Best in KLAS 보고서에서 의료 경험 관리 부문 1위를 차지하게 했습니다.
National Research (NASDAQ: NRC) a annoncé un dividende en espèces trimestriel de 0,12 $ par action, payable le 11 avril 2025, aux actionnaires inscrits au 28 mars 2025. L'entreprise, opérant sous le nom de NRC Health, est un leader dans la gestion de l'expérience en santé depuis plus de 40 ans, se concentrant sur l'humanisation des soins de santé grâce à leur approche Human Understanding®.
NRC Health se spécialise dans l'aide aux systèmes de santé pour développer des relations continues avec les patients grâce à la recherche de marché et à l'analyse des préférences des consommateurs. L'engagement de l'entreprise envers des services centrés sur le patient lui a valu la première place en gestion de l'expérience en santé dans le rapport 2025 Best in KLAS.
National Research (NASDAQ: NRC) hat eine vierteljährliche Bardividende von 0,12 $ pro Aktie angekündigt, die am 11. April 2025 an die Aktionäre ausgezahlt wird, die am 28. März 2025 im Aktienregister stehen. Das Unternehmen, das als NRC Health tätig ist, ist seit über 40 Jahren führend im Bereich des Managements von Gesundheitserfahrungen und konzentriert sich darauf, das Gesundheitswesen durch ihren Ansatz der Human Understanding® zu humanisieren.
NRC Health ist darauf spezialisiert, Gesundheitssysteme dabei zu unterstützen, dauerhafte Beziehungen zu Patienten durch Marktforschung und Analyse der Verbraucherpräferenzen aufzubauen. Das Engagement des Unternehmens für patientenorientierte Dienstleistungen hat ihm den ersten Platz im Bereich Gesundheitsmanagement im Bericht 2025 Best in KLAS eingebracht.
- Consistent dividend payment maintaining shareholder returns
- #1 ranking in Healthcare Experience Management (2025 Best in KLAS report)
- 40+ years of established market presence in healthcare sector
- None.
For more than 40 years, NRC Health (NASDAQ: NRC) has led the charge to humanize healthcare and support organizations in their understanding of each unique individual. NRC Health’s commitment to Human Understanding® helps leading healthcare systems get to know each person they serve not as point-in-time insights, but as an ongoing relationship. Guided by its uniquely empathic heritage, NRC Health’s patient-focused approach, unmatched market research, and emphasis on consumer preferences are transforming the healthcare experience, creating strong outcomes for patients and entire healthcare systems. NRC Health is ranked #1 for Healthcare Experience Management in the 2025 Best in KLAS report.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250324374598/en/
Helen Hrdy
Chief Operating Officer
402-475-2525
Source: NRC Health
FAQ
What is the amount and payment date of NRC's latest quarterly dividend?
What is NRC's ranking in the 2025 Best in KLAS report?
How long has NRC Health been operating in the healthcare sector?
What is NRC Health's main business focus and approach?
